Semantic Scholar uses AI to extract papers important to this topic.
The anticancer drug imatinib is an inhibitor of the platelet-derived growth factor receptor (PDGFR) kinases, which are involved… (More)
Imatinib, a selective inhibitor of c-KIT and Bcr-Abl tyrosine kinases, approved for the treatment of chronic myelogenous leukemia… (More)
- Pakistan journal of pharmaceutical sciences
Imatinib inhibits Bcr-Abl, c-KIT and PDGFR kinases. It is approved for the treatment of chronic myeloid leukemia (CML… (More)
2081 Background: Imatinib (STI-571), approved for treatment of CML & GIST, is administered as daily PO therapy and is primarily… (More)